Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ceballos, Candela
75  Ergebnisse:
Personensuche X
?
1

Mini review: Advances and challenges in CAR-T cell therapy:..:

Ceballos, Candela ; Viguria, Mª Cruz ; Panizo, Carlos..
Frontiers in Hematology.  2 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
2

Optimization of universal allogeneic CAR-T cells combining ..:

Calviño, Cristina ; Ceballos, Candela ; Alfonso, Ana...
Frontiers in Immunology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

Concomitant lymphoplasmacytic lymphoma, multiple myeloma, a..:

Ceballos, Candela ; Alburquerque, Cristina ; Zabalza, Amaya...
Clinical Case Reports.  10 (2022)  4 - p. , 2022
Link: https://doi.org/10.1002/..
 
?
4

Severe intrahepatic cholestasis as the initial manifestatio..:

Martínez-Acitores de la Mata, Diego ; Bravo Meléndez, Silvia ; Ceballos Bolaños, Candela...
Gastroenterología y Hepatología (English Edition).  44 (2021)  1 - p. 29-31 , 2021
Link: https://doi.org/10.1016/..
 
?
5

Effect of the Embolization of Completely Unpurified Islets ..:

Hyon, Sung Ho ; Ceballos, María Candela ; Barbich, Mariana...
Cell Transplantation.  13 (2004)  1 - p. 61-65 , 2004
Link: https://doi.org/10.3727/..
 
?
6

Optimization of universal allogeneic CAR-T cells combining ..:

Calviño, Cristina ; Ceballos, Candela ; Alfonso, Ana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546312/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Concomitant lymphoplasmacytic lymphoma, multiple myeloma, a..:

Ceballos, Candela ; Alburquerque, Cristina ; Zabalza, Amaya...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019880/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
8

CAR density influences antitumoral efficacy of BCMA CAR T c..:

Rodriguez-Marquez, Paula ; Calleja-Cervantes, Maria E ; Serrano, Guillermo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524842/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

DataSheet_6_Optimization of universal allogeneic CAR-T cell..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s007.  , 2023
Link: https://doi.org/10.3389/..
 
?
10

Table_2_Optimization of universal allogeneic CAR-T cells co..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s012.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

DataSheet_4_Optimization of universal allogeneic CAR-T cell..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s005.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

Table_6_Optimization of universal allogeneic CAR-T cells co..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s016.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

DataSheet_7_Optimization of universal allogeneic CAR-T cell..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s008.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Table_3_Optimization of universal allogeneic CAR-T cells co..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s013.  , 2023
Link: https://doi.org/10.3389/..
 
?
15

Table_4_Optimization of universal allogeneic CAR-T cells co..:

Cristina Calviño ; Candela Ceballos ; Ana Alfonso...
doi:10.3389/fimmu.2023.1270843.s014.  , 2023
Link: https://doi.org/10.3389/..
 
1-15